|
| Press Releases |
|
 |
|
| Tuesday, March 4, 2025 |
|
|
Micreos Pharmaceuticals 與生物製劑 CDMO Northway Biotech 合作推動其工程化內溶素療法製造計畫 |
| more info >> |
|
|
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program |
| Micreos Pharmaceuticals AG ("Micreos"), a preclinical-stage biopharmaceutical company, specializing in developing Engineered Endolysin therapies to target harmful pathogens that cause disease aggravation, has entered into a strategic partnership with Northway Biotech ("NBT"), a Contract Development and Manufacturing Organization (CDMO) to develop scalable cGMP production processes for Micreos' biologic therapeutic MEndoB, which is the first-in-class dual-active domain targeted medicine that will enter the clinic in the coming months as an investigational therapeutic to treat Atopic Dermatitis. more info >> |
|
| Wednesday, February 5, 2025 |
|
|
Mallia Therapeutics 與 Northway Biotech 宣布合作生產可溶性 CD83 蛋白 用於脫髮治療 |
| Mallia Therapeutics（「Mallia」）是一家致力於開發新型脫髮治療方案的生物製藥公司，Northway Biotech（「NBT」）則是一家專業從事生物製劑的合同開發與製造組織（CDMO）。雙方宣布建立合作夥伴關係，共同開發 Mallia 的可溶性 CD83 蛋白（sCD83）生產工藝，並負責其製造，該治療方案旨在促進毛囊形成與生長。 more info >> |
|
| Tuesday, February 4, 2025 |
|
|
Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment |
| Mallia Therapeutics ("Mallia"), a biopharmaceutical company developing novel treatments for hair loss, and Northway Biotech ("NBT"), a biologics Contract Development and Manufacturing Organization (CDMO), have announced a partnership for the development of the production process and manufacturing of Mallia's soluble CD83 protein (sCD83), a treatment aimed at promoting hair follicle formation and growth. more info >> |
|
| Tuesday, August 1, 2023 |
|
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology |
| iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. more info >> |
|
|
iTolerance, Inc. and Northway Biotech Announce Partnership Agreement for Manufacturing of Streptavidin-FasL Fusion Protein for Innovative iTOL-100 Immunomodulatory Technology |
| iTOL-100 technology has broad applicability and can be applied to both allogenic and stem cell-derived organoids across a number of diseases. Manufacturing agreement supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102. more info >> |
|
| Thursday, May 25, 2023 |
|
|
Northway Biotech Set to Launch Advanced Microbial and Mammalian GMP Facilities in Massachusetts |
| Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art cGMP manufacturing site in Vilnius, Lithuania, announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts. This significant accomplishment further solidifies Northway Biotech's standing as an influential player in the global biopharmaceutical landscape. more info >> |
|
| Wednesday, May 17, 2023 |
|
|
tiakis Biotech AG and Northway Biotech: Successful Tech Transfer and Expansion of Manufacturing Capabilities for Tiprelestat |
| tiakis Biotech AG (tiakis), in collaboration with its CDMO partner Northway Biotech, is pleased to announce the successful completion of a technology transfer and ramp-up of manufacturing capabilities for Tiprelestat, a pioneering anti-inflammatory and tissue-protective drug being developed for the prevention of postoperative inflammatory complications following major surgery, treatment of COVID-19 and pulmonary arterial hypertension. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
PerfectSwell(R) 測試啟動於聖保羅獨家衝浪俱樂部
Mar 4, 2025 23:05 HKT/SGT
|
|
|
PerfectSwell(R) Testing Begins at the Exclusive Sao Paulo Surf Club
Mar 4, 2025 23:05 HKT/SGT
|
|
|
Micreos Pharmaceuticals 與生物製劑 CDMO Northway Biotech 合作推動其工程化內溶素療法製造計畫
Mar 4, 2025 23:00 HKT/SGT
|
|
|
GA-ASI 在 Orange Flag 25-1 飛行測試中運行政府參考自主堆疊
Mar 4, 2025 23:00 HKT/SGT
|
|
|
Graid Technology Secures $30M Series B to Accelerate Growth in Data Storage & Protection Market
Mar 4, 2025 23:00 HKT/SGT
|
|
|
GA-ASI Flies Government Reference Autonomy Stack at Orange Flag 25-1
Mar 4, 2025 23:00 HKT/SGT
|
|
|
GA-ASI 歡迎美國空軍對新型 CCA 的命名：YFQ-42A
Mar 4, 2025 22:00 HKT/SGT
|
|
|
周大福人壽成為啟德體育園開幕禮唯一鑽石贊助商
Mar 4, 2025 21:57 HKT/SGT
|
|
|
歷史性全球反詐騙峰會在倫敦召開，共同打擊日益猖獗的網路詐騙
Mar 4, 2025 21:56 HKT/SGT
|
|
|
重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據 療效顯著 多重代謝獲益 市場前景廣闊
Mar 4, 2025 21:55 HKT/SGT
|
|
|
穆罕默德·本·扎耶德人工智慧大學（MBZUAI）推出首個同類本科人工智慧課程，協助未來AI領袖成長
Mar 4, 2025 21:54 HKT/SGT
|
|
|
香港国际珠宝展今日盛大开幕 汇聚环球创新设计
Mar 4, 2025 21:10 HKT/SGT
|
|
|
The 17th Annual Global CSR & ESG Summit 2025 Concludes in Ho Chi Minh City, Setting New Standards in Sustainability
Mar 4, 2025 20:47 HKT/SGT
|
|
|
香港國際珠寶展今日盛大開幕 匯聚環球創新設計
Mar 4, 2025 20:45 HKT/SGT
|
|
|
LaFleur Minerals to Restart Gold Milling at Beacon Gold Mill in Val-d'Or, Quebec
Mar 4, 2025 20:30 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
